Glycoxidative damage to human DNA: Neo-antigenic epitopes on DNA molecule could be a possible reason for autoimmune response in type 1 diabetes

Glycobiology

Volumn 24, Issue 3, 2014, Pages 281-291

  Ahmad, Saheem ^a   Moinuddin, M ^a   Shahab, Uzma ^a   Habib, Safia ^a   Salman Khan, M ^b   Alam, Khursheed ^a   Ali, Asif ^c  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b INTEGRAL UNIVERSITY   (India)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

advanced glycation end products; diabetes; DNA; glycation; methylglyoxal

Indexed keywords

ADVANCED GLYCATION END-PRODUCTS; DIABETES; DNA; GLYCATION; METHYLGLYOXAL;

AUTOIMMUNITY; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 1; DNA; DNA DAMAGE; EPITOPES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYMPHOCYTES; PENICILLAMINE; PYRIDOXAL; PYRUVALDEHYDE;

EID: 84894249789     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt109     Document Type: Article

References (41)

1. Ahmad MI, Ahmad S, Moinuddin. 2011. Preferential recognition of methylglyoxal-modified calf thymus DNA by circulating antibodies in cancer patients. Ind J Biochem Biophys. 48:290-296.
2. Ahmad S, Moinuddin, Dixit K, Shahab U, Alam K, Ali A. 2011. Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu2+. Biochem Biophys Res Commun. 407:568-574.
3. Ahmad S, Akhter F, Shahab U, Moinuddin, Khan MS. 2013. Studies on glycation of human low density lipoprotein: A functional insight into physicochemical analysis. Int J Biol Macro. 62:167-71.
4. Ahmad S, Shahab U, Baig MH, Khan MS, Khan M. Sajid, Saeed M, Srivastava AK, Moinuddin. 2013. Inhibitory effect of Metformin and Pyridoxamine in the formation of early, intermediate and advanced glycation end-products. PLoS ONE. 8(9):e72128.
5. Akhter F, Khan MS, Shahab U, Moinuddin, Ahmad S. 2013. Bio-physical characterization of ribose induced glycation: A mechanistic study on DNA perturbations. Int J Biol Macro. 58:206-210.
6. Baynes JW. 2001. The role of AGEs in aging: Causation or correlation. Exp Gerontol. 36:1527-1537.
7. Beauchamp C, Fridovich I. 1971. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem. 44:276-287.
8. Bucala R, Model P, Anthony C. 1984. Modification of DNA by reducing sugars: A possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Biochemistry. 81:105-109.
9. Bucala R, Model P, Russel M, Cerami A. 1985. Modification of DNA by glucose 6-phosphate induces DNA rearrangements in an Escherichia coli plasmid. Proc Natl Acad Sci USA. 82:8439-8442.
10. Bucala R, Tracey KJ, Cerami A. 1991. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest. 87:432-438.
11. Dutta U, Cohenford MA, Dain JA. 2005. Nonenzymatic glycation of DNA nucleosides with reducing sugars. Anal Biochem. 345:171-180.
12. Frischmann M, Bidmon C, Angerer J, Pischetsrieder M. 2005. Identification of DNA adducts of methylglyoxal. Chem Res Toxicol. 18:1586-1592.
13. Habib S, Moinuddin, Ali A, Ali R. 2009. Preferential recognition of peroxynitrite modified human DNA by circulating autoantibodies in cancer patients. Cell Immunol. 254:117-123.
14. Khan WA, Alam K, Moinuddin. 2007. Catechol-estrogen modified DNA: A better antigen for cancer autoantibody. Arch Biochem Biophys. 465:293-300.
15. Knerr T, Severin T. 1993. Reaction of glucose with guanosine. Tetrahedron Lett. 34:7389-7390.
16. Larisch B, Pischetsrieder M, Severin T. 1997. Formation of guanosine adducts from l-ascorbic acid under oxidative conditions. Bioorg Med Chem Lett. 7:2681-2686.
17. Lee A, Cerami A. 1987. The formation of reactive intermediate(s) of glucose 6-phosphate and lysine capable of rapidly reacting with DNA. Mutat Res. 179:151-158.
18. Levi B, Werman MJ. 2003. Fructose and related phosphate derivatives impose DNA damage and apoptosis in L5178Y mouse lymphoma cells. J Nutr Biochem. 14:49-60.
19. Li H, Nakmura S, Miyazaki S, Morita T, Suzuki M, Pischetsrieder M, Niwa T. 2006. Carboxyethyl-2′-deoxyguanosine, a DNA glycation marked, in kidneys and aortas of diabetic and uremic patients. Kidney Int. 69:388-392.
20. Matsuo N, Ross PM. 1987. Measurement of interstrand cross-link frequency and distance between interruptions in DNA exposed to 4,5′,8- trimethylpsoralen and near-ultraviolet light. Biochemistry. 26:2001-2009.
21. Moinuddin, Dixit K, Ahmad S, Shahab U, Habib S, Naim M, Alam K, Ali A. 2012. Human DNA damage by the synergistic action of 4-aminobiphenyl and nitric oxide: An immunochemical study. Environ Toxicol. doi:10.1002/tox.21782.
22. Monnier VM, Cerami A. 1981. Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science. 211:491-493.
23. Mustafa I, Ahmad S, Dixit K, Moinuddin, Ahmad J, Ali A. 2012. Glycated human DNA is a preferred antigen for anti-DNA antibodies in diabetic patients. Diabetes Res Clin Pract. 95:98-104.
24. Ochs S, Severin T. 1994. Reaction of 2′-deoxyguanosine with glyceraldehyde. Liebigs Ann Chem. 5:851-853.
25. Ortwerth BJ, James H, Simpson G, Linetsky M. 1998. The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones. Biochem Biophys Res Commun. 245:161-165.
26. Papoulis A, al-Abed Y, Bucala R. 1995. Identification of N2-(1-carboxyethyl) guanine (CEG) as a guanine advanced glycosylation end product. Biochemistry. 34:648-655.
27. Pethig R, Szent-Gyorgyi A. 1977. Electronic properties of the caseinmethylglyoxal complex. Proc Natl Acad Sci USA. 74:226-228.
28. Raheem M, Iram S, Sajid KM, Khan MS, Shukla AR, Srivastava AK, Ahmad S. 2013. Glycation-assisted synthesized gold nanoparticles inhibit growth of bone cancer cells. Colloid and Surfaces-B. http://dx.doi.org/10.1016/j. colsurfb.2013.12.008.
29. Schleicher ED, Bierhaus A, Haring HU, Nawroth PP, Lehmann R. 2001. Chemistry and pathobiology of advanced glycation end products. Contrib Nephrol. 131:1-9.
30. Schleicher ED, Wagner E, Nerlich AG. 1997. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 99:457-468.
31. Schmitt A, Schmitt J, Munch G, Gasic-Milencovic J. 2005. Characterization of advanced glycation end products for biochemical studies: Side chain modifications and fluorescence characteristics. Anal Biochem. 338:201-215.
32. Seidel W, Pischetsrieder M. 1998. DNA-glycation leads to depurination by the loss of N2-carboxyethylguanine in vitro. Cell Mol Biol. 44:1165-1170.
33. Sengupta B, Swenson J. 2005. Properties of normal and glycated human hemoglobin in presence and absence of antioxidant. Biochem Biophys Res Commun. 334:954-959.
34. Shahab U, Moinuddin, Ahmad S, Dixit K, Abidi SMA, Alam K, Ali A. 2012. Acquired immunogenicity of human DNA damaged by N-hydroxy-N-acetyl-4- aminobiphenyl. IUBMB Life. 64:340-345.
35. Shahab U, Moinuddin, Ahmad S, Dixit K, Habib S, Alam K, Ali A. 2013. Genotoxic effect of N-hydroxy-4-acetylaminobiphenyl on human DNA: Implications in bladder cancer. PL0S One. 8(1):e53205.
36. Shishido K, Ando T. 1974. Cleavage of ultraviolet light-irradiated DNA by single strand-specific S1 endonuclease. Biochem Biophys Res Commun. 59:1380-1388.
37. Simpson JA, Narita S, Gieseg S, Gebicki S, Gebicki JM, Dean RT. 1992. Long-lived reactive species on free-radical-damaged proteins. Biochem J. 282:621-624.
38. Singh R, Barden A, Mori T, Beilin L. 2001. Advanced glycation end-products: A review. Diabetologia. 44:129-146.
39. Thornalley PJ. 1996. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy. Genet Pharmacol. 27:565-573.
40. Turk Z, Ljubic S, Turk N, Benko B. 2001. Detection of autoantibodies against advanced glycation end products and AGE immune complexes in serum of patients with diabetes mellitus. Clin Chim Acta. 303(1-2):105-115.
41. Yamasaki H, Pulkabrek P, Grurberger D, Weinstein IB. 1997. Differential excision from DNA of the C-8 and N2 guanosine adducts of N-acetyl-2- aminofluorene by single strand-specific endonucleases. Cancer Res. 37:3756-3760.